Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Objectives To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance. Design Randomised double blind (clinician, patient, outcomes assessor) placebo...

ver descrição completa

Detalhes bibliográficos

Publicado no:	BMJ
Principais autores:	Ballard, Clive, Margallo-Lana, Marisa, Juszczak, Edmund, Douglas, Simon, Swann, Alan, Thomas, Alan, O'Brien, John, Everratt, Anna, Sadler, Stuart, Maddison, Clare, Lee, Lesley, Bannister, Carol, Elvish, Ruth, Jacoby, Robin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2005
Assuntos:	Papers
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC556156/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15722369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38369.459988.8F
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!